Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8

CRISPR activation CRISPR interference T cell exhaustion cancer immunology chromatin accessibility enhancer gene regulation single-cell ATAC-seq tumor-infiltrating T cells

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
16 02 2023
Historique:
received: 20 07 2022
revised: 22 11 2022
accepted: 23 12 2022
pubmed: 20 1 2023
medline: 25 2 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

Despite extensive studies on the chromatin landscape of exhausted T cells, the transcriptional wiring underlying the heterogeneous functional and dysfunctional states of human tumor-infiltrating lymphocytes (TILs) is incompletely understood. Here, we identify gene-regulatory landscapes in a wide breadth of functional and dysfunctional CD8

Identifiants

pubmed: 36657444
pii: S1097-2765(22)01212-6
doi: 10.1016/j.molcel.2022.12.029
pii:
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-636.e10

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Dania Riegel (D)

Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.

Elena Romero-Fernández (E)

Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.

Malte Simon (M)

Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Akinbami Raphael Adenugba (AR)

Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.

Katrin Singer (K)

Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany; Department of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany.

Roman Mayr (R)

Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, 93053 Regensburg, Germany.

Florian Weber (F)

Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.

Mark Kleemann (M)

Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.

Charles D Imbusch (CD)

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Marina Kreutz (M)

Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.

Benedikt Brors (B)

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Ines Ugele (I)

Department of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany.

Jens M Werner (JM)

Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.

Peter J Siska (PJ)

Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.

Christian Schmidl (C)

Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany. Electronic address: christian.schmidl@ukr.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH